Join a study

1) Actinic Keratosis (sun damaged skin) 
2) High cholesterol 
3) High cholesterol
4) High cholesterol 
5) Gout 
6) Gout
7) Gout 
8) Lupus (Fremont Location)

Study participants will receive the study drug, and all study related testing and examinations at no cost. Compensation for time and travel may be available.

1) Actinic Keratosis (sun damage) study

If you have been diagnosed with Actinic Keratosis, you may be eligible to participate in a clinical research study of an investigational cream.  This research study is being conducted to compare the safety and effectiveness of a study cream for Actinic Keratosis to that of a marketed cream or a placebo.

2) High Cholesterol study #1

The purpose of this research study is to compare the effects of the study drug, bococizumab (also called PF-04950615), with a placebo. 

There will be about 9,000 people enrolled in this study. The study is being done at about 1,489 different research sites in approximately 35 countries. About 15 people will be enrolled at our site.

You may be in this study for up to 50 months. However the study duration may be shorter as the study will be terminated when the endpoints have been met or 12 months after the last subject has entered the study. You will need to visit the research site at up to approximately 20 times with 2 weeks to 4 months intervals during the study.

3) High Cholesterol study #2

 The purpose of this research study is to evaluate the safety and effectiveness of an experimental study drug, ARI-3037MO, compared to a placebo (sugar pill) in reducing triglyceride (lipid/fat) levels of subjects with severe hypertriglyceridemia. The study drug, ARI-3037MO, is a niacin analog, a B vitamin that has been shown to lower triglyceride levels in people with high levels of these blood fats. “

The Study Drug A drug called niacin has been used for many years in patients with high levels of triglycerides and low levels of “good cholesterol” also known as HDL-C. Recent studies have looked at the known risks of niacin as well as the number of patients who have been helped with this medication. They have concluded that the risks of currently available forms of niacin may be greater than the potential benefit and therefore, use of the currently available forms should be limited to patients with high risks for cardiac events who are unable to take the cholesterol-lowering drugs known as “statins” (Lipitor, Zocor, etc).

Your participation in the study will last approximately 6 months.

4) High Cholesterol study #3

Are you living with high cholesterol?

High cholesterol is common, but can lead to serious health problems like heart attack and stroke.

5) Gout study #1

This is a 5-9 year study to evaluate the safety of Febuxostat (Uloric) and Allopurinol. Study-related medical care and services are provided at no cost to study participants. Compensation for time and travel will be provided.

You may qualify to participate if you:

Female 55 years or older
Male 50 years or older
Have gout

6) Gout study #2

The purpose of this 3 month study is to evaluate the effectiveness and safety of an investigational new febuxostat (Uloric)  tablet (XR) in comparison with the marketed product (febuxostat IR (Uloric)) and placebo (inactive substance) in subjects with gout.

You may qualify for an gout research study if you:

18 years of age older
Diagnosed with gout
There are other study requirements that will determine whether individuals may participate in this clinical research study.

6) Gout Study #3

A Phase IIA, open-label, multicenter, active-controlled, parallel-group clinical trial designed to evaluate the safety and efficacy of two doses of Bucillamine compared with low-dose Colchicine in the treatment of patients with acute gout flare.

Please call for study details. (925) 413-1451

7) Lupus (Fremont Location)

A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab.

Future studies include: GERD, Weight Loss, Coronary Heart Disease, Type 2 Diabetes, , Back Pain,  Erectile Dysfunction, Hypertension, COPD, IBS, Opioid Constipation, Arthritis

To find out more information about a specific study, please call 925-413 1451 or email  Our staff will be able to tell you more about the research study and answer your questions.